Amelogenesis Imperfecta Genetics and Clinical Management

Amelogenesis imperfecta (AI) encompasses a group of inherited disorders characterised by defective enamel development and mineralisation. Genetic studies have identified over twenty causative genes encoding enamel matrix proteins, proteolytic enzymes, ion transporters and adhesion molecules. Mutations in these genes give rise to phenotypes ranging from thin, pitted enamel (hypoplastic AI) to poorly mineralised, soft enamel (hypomaturation AI). Advances in genomic sequencing have refined the diagnostic pathway, enabling targeted genetic testing to complement clinical and radiographic assessment. Early genetic diagnosis informs prognosis, supports family counselling and guides personalised restorative strategies. Clinical management combines preventive care to reduce sensitivity and caries risk with minimally invasive restorations in mild cases, and full-coverage crowns or prosthetic rehabilitation in severe presentations. Multidisciplinary collaboration between geneticists, paediatric dentists and restorative specialists is essential to optimise function, aesthetics and quality of life from childhood through adulthood.

Research from Nature Portfolio

Recent studies have employed three-dimensional imaging and live-cell tracking in transgenic mouse models to elucidate how matrix metalloproteinase-20 modulates ameloblast movement during the secretory stage of enamel formation. Disruption or overexpression of this protease alters cell adhesion gene networks, resulting in irregular ameloblast migration and enamel architecture. Another body of work has explored the role of the keratin cytoskeleton in enamel-forming cells, revealing that mutations in the FAM83H protein disrupt desmosome assembly and keratin filament organisation in ameloblasts. These findings highlight non-matrix pathways influencing enamel integrity and open new avenues for understanding molecular mechanisms underlying AI.

Amelogenesis Imperfecta Genetics and Clinical Management publication trend

The graph below shows the total number of articles in amelogenesis imperfecta genetics and clinical management across all publications each year (not limited to Nature Index journals).

Technical terms

Ameloblast: An enamel-secreting cell responsible for depositing and mineralising the enamel matrix.

Hypoplastic amelogenesis imperfecta: A form of AI characterised by reduced enamel thickness due to impaired matrix secretion.

Hypomaturation amelogenesis imperfecta: A form of AI in which enamel volume is near normal but hardness and mineral density are deficient.

Enamel matrix proteins: Secreted proteins, including amelogenin and ameloblastin, that form a scaffold for mineral deposition during amelogenesis.

Genotype–phenotype correlation: The relationship between specific genetic variants and the resulting clinical presentation.

References

1. Novel Ameloblastin Variants, Contrasting Amelogenesis Imperfecta Phenotypes. Journal of Dental Research (2023).
2. Advances in clinical diagnosis and management of amelogenesis imperfecta in children and adolescents. Journal of Dentistry (2024).
3. AMELX Mutations and Genotype–Phenotype Correlation in X-Linked Amelogenesis Imperfecta. International Journal of Molecular Sciences (2024).
4. Mobility gene expression differences among wild-type, Mmp20 null and Mmp20 over-expresser mice plus visualization of 3D mouse ameloblast directional movement. Scientific Reports (2023).
5. Amelogenesis Imperfecta; Genes, Proteins, and Pathways. Frontiers in Physiology (2017).
6. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Scientific Reports (2016).